StockData
Ironwood Pharmaceuticals Inc logo

Ironwood Pharmaceuticals Inc (IRWD) stock

IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.78−0.09 (-1.85%)

Close on Nov 18, 2026Market cap $789.85MP/E 6.2Yield –

Ironwood Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

Ironwood Pharmaceuticals's gross margin for the twelve months ending Dec 31, 2020 was 99.2%. For fiscal 2020 it was 99.2%, against 94.4% the year before. The highest annual figure on record is 100.0% in fiscal 2015.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2020Dec 31, 202099.2%+4.8
FY2019Dec 31, 201994.4%+3.9
FY2018Dec 31, 201890.6%−3.0
FY2017Dec 31, 201793.6%−5.7
FY2016Dec 31, 201699.3%−0.7
FY2015Dec 31, 2015100.0%+6.9
FY2014Dec 31, 201493.1%+24.6
FY2013Dec 31, 201368.5%−30.8
FY2012Dec 31, 201299.4%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2020Dec 31, 202099.2%+8.0
Q3 FY2020Sep 30, 2020100.0%+0.4
Q2 FY2020Jun 30, 2020100.0%+11.1
Q1 FY2020Mar 31, 202097.2%−1.3
Q4 FY2019Dec 31, 201991.3%+7.7
Q3 FY2019Sep 30, 201999.6%+6.6
Q2 FY2019Jun 30, 201988.9%−6.1
Q1 FY2019Mar 31, 201998.5%+2.3
Q4 FY2018Dec 31, 201883.6%−6.9
Q3 FY2018Sep 30, 201893.0%−0.0
Q2 FY2018Jun 30, 201895.0%+0.4
Q1 FY2018Mar 31, 201896.2%−2.8
Q4 FY2017Dec 31, 201790.5%–
Q3 FY2017Sep 30, 201793.0%–
Q2 FY2017Jun 30, 201794.6%–
Q1 FY2017Mar 31, 201799.0%–

More Ironwood Pharmaceuticals figures

See a number that looks wrong?